MBIO - Mustang Bio stock jumps 10% on FDA acceptance of new drug application
2023-10-26 09:44:31 ET
More on Mustang Bio
Mustang Bio down 8% following data on CAR-T lymphoma asset
Seeking Alpha’s Quant Rating on Mustang Bio
Historical earnings data for Mustang Bio
Financial information for Mustang Bio
For further details see:
Mustang Bio stock jumps 10% on FDA acceptance of new drug application